Anonymous ID: 99d02a July 25, 2021, 5:56 p.m. No.14199087   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

>>14199057

 

You're an infectious vaginal blood fart. You sit the fuck down.

 

I just showed you the MIL deaths 26 or 367 were way out of line on a % basis.

 

Second, how about your hero General Milley:

Obese

Definite comorbidities

50+

 

GFY

Anonymous ID: 99d02a July 25, 2021, 6:26 p.m. No.14199286   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

https://www.federalregister.gov/documents/2020/03/17/2020-05484/declaration-under-the-public-readiness-and-emergency-preparedness-act-for-medical-countermeasures

 

Summary: Azar declared the emergency not using PCR tests as an initial determinant.

 

To date, United States traveler-associated cases have been identified in a number of States and community-based transmission is suspected. On January 31, 2020, Secretary Azar declared a public health emergency pursuant to section 319 of the PHS Act, 42 U.S.C. 247d, for the entire United States to aid in the nation's health care community response to the COVID-19 outbreak.[1] The outbreak remains a significant public health challenge that requires a sustained, coordinated proactive response by the Government in order to contain and mitigate the spread of COVID-19.[2]

 

DECLARATION

Declaration for Public Readiness and Emergency Preparedness Act Coverage for medical countermeasures against COVID-19.

 

I. DETERMINATION OF PUBLIC HEALTH EMERGENCY

42 U.S.C. 247d-6d(b)(1)

 

I have determined that the spread of SARS-CoV-2 or a virus mutating therefrom and the resulting disease COVID-19 constitutes a public health emergency.

II. FACTORS CONSIDERED

42 U.S.C. 247d-6d(b)(6)

 

I have considered the desirability of encouraging the design, development, clinical testing, or investigation, manufacture, labeling, distribution, formulation, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of the Covered Countermeasures.

 

III. RECOMMENDED ACTIVITIES

42 U.S.C. 247d-6d(b)(1)

 

I recommend, under the conditions stated in this Declaration, the manufacture, testing, development, distribution, administration, and use of the Covered Countermeasures.

 

et alโ€ฆโ€ฆ

Anonymous ID: 99d02a July 25, 2021, 6:35 p.m. No.14199344   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

POTUS pushing vax simply because his efforts brought it forward.

 

I gotta just say my instincts told me NO long ago.

 

He you should take it but you have to decide.

 

Is he splitting the razors edge saying what he has said? (It was my vax but maybe don't take it).

 

There is a political angle both sides playing - remember Joe and Kunt saying don't take the Trump vax.

Anonymous ID: 99d02a July 25, 2021, 6:39 p.m. No.14199381   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>9623 >>9624

>>14199316

FDA is hereby announcing the following Authorizations for molecular diagnostic and antigen tests for COVID-19, excluding multi-analyte tests:โ€‰[3]

 

Visby Medical, Inc.'s Visby Medical COVID-19, issued September 16, 2020;

GK Pharmaceuticals Contract Manufacturing Operations' GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT, issued September 18, 2020;

KimForest Enterprise Co., Ltd.'s KimForest SARS-CoV-2 Detection Kit v1, issued September 21, 2020;

Vela Operations Singapore Pte. Ltd.'s ViroKey SARS-CoV-2 RT-PCR Test v2.0, issued September 22, 2020;

Quadrant Biosciences Inc.'s Clarifi COVID-19 Test Kit, issued September 22, 2020;

Clear Labs, Inc.'s Clear Dx SARS-CoV-2 Test, issued September 23, 2020;

Genetrack Biolabs, Inc.'s Genetrack SARS-CoV-2 Molecular Assay, issued September 25, 2020;

National Jewish Health's SARS-CoV-2 MassArray Test, issued September 29, 2020;

Akron Children's Hospital's Akron Children's Hospital SARS-CoV-2 Assay, issued September 29, 2020;

CENTOGENE US, LLC's CentoSure SARS-CoV-2 RT-PCR Assay, issued September 29, 2020;

Aeon Global Health's Aeon Global Health SARS-CoV-2 Assay, issued September 30, 2020;

Alimetrix, Inc.'s Alimetrix SARS-CoV-2 RT-PCR Assay, issued September 30, 2020;

Tempus Labs, Inc.'s iC SARS-CoV2 Test, issued October 1, 2020;

UMass Memorial Medical Center's UMass Molecular Virology Laboratory 2019-nCoV rRT-PCR Dx Panel, issued October 1, 2020;

SEASUN BIOMATERIALS, Inc.'s AQ-TOP COVID-19 Rapid Detection Kit PLUS, issued October 5, 2020;

University of California, Los Angeles's (UCLA's) UCLA SwabSeq COVID-19 Diagnostic Platform, issued October 6, 2020;

Access Bio, Inc.'s CareStart COVID-19 Antigen, issued October 8, 2020;

LumiraDx UK Ltd.'s LumiraDx SARS-CoV-2 RNA STAR Complete, issued October 14, 2020;

Celltrion USA, Inc.'s Sampinute COVID-19 Antigen MIA, issued October 23, 2020;

Agena Bioscience, Inc.'s MassARRAY SARS-CoV-2 Panel, issued October 26, 2020;

Lucira Health, Inc.'s Lucira COVID-19 All-In-One Test Kit, issued November 17, 2020;

Gravity Diagnostics, LLC's Gravity Diagnostics SARS-CoV-2 RT-PCR Assay, issued November 23, 2020;

Cepheid's Xpert Omni SARS-CoV-2, issued November 27, 202;

Luminostics, Inc.'s Clip COVID Rapid Antigen Test, issued December 7, 2020;

Laboratory Corporation of America's Pixel by LabCorp COVID-19 Test Home Collection Kit, issued December 9, 2020;

ResearchDx, Inc., DBA Pacific Diagnostics' PacificDx Covid-19 Test, issued December 11, 2020;

RCA Laboratory Services LLC dba GENETWORx's GENETWORx Covid-19 Nasal Swab Test, issued December 15, 2020;

Ellume Limited's Ellume COVID-19 Home Test, issued December 15, 2020;

Abbott Diagnostics Scarborough, Inc.'s BinaxNOW COVID-19 Ag Card Home Test, issued December 16, 2020;

Materials and Machines Corporation of America's (DBA MatmaCorp, Inc.) MatMaCorp COVID-19 2SF Test, issued December 17, 2020;

Quidel Corporation's QuickVue SARS Antigen Test, issued December 18, 2020;

Quidel Corporation's Solana SARS-CoV-2 Assay, issued December 23, 2020;

Cepheid's Xpert Xpress SARS-CoV-2 DoD, issued December 23, 2020;

Quanterix Corporation's Simoa SARS-CoV-2 N Protein Antigen Test, issued January 5, 2021;

Start Printed Page 21751

Ortho Clinical Diagnostics, Inc.'s VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent Pack used in combination with the VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Calibrator, issued January 11, 2021;

SML GENETREE Co., Ltd.'s Ezplex SARS-CoV-2 G Kit, issued January 13, 2021;

Bio-Rad Laboratories, Inc.'s Bio-Rad Reliance SARS-CoV-2 RT-PCR Assay Kit, issued January 15, 2021;

Ambry Genetics Laboratory's Ambry COVID-19 RT-PCR Test, issued January 22, 2021;

Clinomics USA Inc.'s Clinomics TrioDx RT-PCR COVID-19 Test, issued February 4, 2021;

Visby Medical, Inc.'s Visby Medical COVID-19 Point of Care Test, issued February 8, 2021;

Grifols Diagnostic Solutions Inc.'s Procleix SARS-CoV-2 Assay, issued February 10, 2021;

Assurance Scientific Laboratories' Assurance SARS-CoV-2 Panel DTC, issued February 13, 2021; and

Gravity Diagnostics, LLC's Gravity Diagnostics SARS-CoV-2 RT-PCR for use with DTC kits, issued February 13, 2021.